Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis

被引:65
作者
Friedman, CR
Quinn, GC
Kreiswirth, BN
Perlman, DC
Salomon, N
Schluger, N
Lutfey, M
Berger, J
Poltoratskaia, N
Riley, LW
机构
[1] CORNELL UNIV MED COLL,DEPT MED,NEW YORK,NY
[2] NYU,BELLEVUE HOSP CTR,NEW YORK,NY 10016
[3] BETH ISRAEL MED CTR,DEPT MED,NEW YORK,NY 10003
[4] ST BARNABAS HOSP,PUBL HLTH RES INST,TB CTR,NEW YORK,NY
[5] ST BARNABAS HOSP,DEPT MED,NEW YORK,NY
关键词
D O I
10.1086/514067
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In New York City, a large proportion of new tuberculosis cases has been caused by 1 drug-susceptible strain (called C strain) of Mycobacterium tuberculosis, Between 1991 and 1994, among >600 tuberculosis patients consecutively identified in four large hospitals in the city, 54 with C strain, 69 with non-C Cluster pattern strains, and 42 with noncluster pattern strains were studied, Susceptibility to reactive nitrogen intermediates (RNI) of selected isolates was compared, In a case-control analysis, 51% of patients with C strain, 28% with non-C cluster strains (P<.05), and 14% with noncluster strains (P<.01) were found to be injection drug users, C strain but not 13 other unrelated isolates were resistant to RNI, Injection drug use may provide a selective pressure for an RNI-resistant tubercle bacillus to emerge, which may give the organism a biologic advantage and explain the widespread dissemination of C strain M. tuberculosis within the city.
引用
收藏
页码:478 / 484
页数:7
相关论文
共 50 条
  • [31] Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
    Chang, Vincent K.
    Imperial, Marjorie Z.
    Phillips, Patrick P. J.
    Velasquez, Gustavo E.
    Nahid, Payam
    Vernon, Andrew
    Kurbatova, Ekaterina V.
    Swindells, Susan
    Chaisson, Richard E.
    Dorman, Susan E.
    Johnson, John L.
    Weiner, Marc
    Sizemore, Erin E.
    Whitworth, William
    Carr, Wendy
    Bryant, Kia E.
    Burton, Deron
    Dooley, Kelly E.
    Engle, Melissa
    Nsubuga, Pheona
    Diacon, Andreas H.
    Nhung Nguyen Viet
    Dawson, Rodney
    Savic, Radojka M.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [32] Comparison of isoniazid monoresistant tuberculosis with drug-susceptible tuberculosis and multidrug-resistant tuberculosis
    L. Fox
    M. R. Kramer
    I. Haim
    R. Priess
    A. Metvachuk
    D. Shitrit
    European Journal of Clinical Microbiology & Infectious Diseases, 2011, 30
  • [33] Proteomic analysis of drug-susceptible and multidrug-resistant nonreplicating Beijing strains of Mycobacterium tuberculosis cultured in vitro
    Saiboonjan, Bhanubong
    Roytrakul, Sittiruk
    Sangka, Arunnee
    Lulitanond, Viraphong
    Faksri, Kiatichai
    Namwat, Wises
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2021, 26
  • [34] Benzylsulfanyl benzo-heterocycle amides and hydrazones as new agents against drug-susceptible and resistant Mycobacterium tuberculosis
    Lu, Xiaoyun
    Hu, Xianglong
    Liu, Zhiyong
    Zhang, Tianyu
    Wang, Ruibing
    Wan, Baojie
    Franzblau, Scott G.
    You, Qidong
    MEDCHEMCOMM, 2017, 8 (06) : 1303 - 1306
  • [35] Design, synthesis, and evaluation of novel diphenyl ether derivatives against drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis
    Kar, Sidhartha S.
    Bhat, Varadaraj G.
    Shenoy, Vishnu P.
    Bairy, Indira
    Shenoy, G. Gautham
    CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 93 (01) : 60 - 66
  • [36] Risk of Treatment Failure in Patients with Drug-susceptible Pulmonary Tuberculosis in China
    WANG Ni
    MA Yan
    LIU YU Hong
    DU Jian
    ZHANG Hui
    XIE Shi Heng
    Zhu Kun
    LYU Xiao Ya
    SHU Wei
    WANG Hong Hong
    ZHU Guo Feng
    TAN Shou Yong
    FU Yan Yong
    MA Li Ping
    ZHANG Lian Ying
    LIU Fei Ying
    HU Dai Yu
    ZHANG Yan Ling
    LI Xiang Qun
    LI Liang
    Biomedical and Environmental Sciences, 2016, 29 (08) : 612 - 617
  • [37] Outcomes of extended duration therapy for drug-susceptible cavitary pulmonary tuberculosis
    Lee, Hyun
    Sohn, Jang Won
    Sim, Yun Su
    Shin, Tae Rim
    Kim, Dong-Gyu
    Choi, Hayoung
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [38] Promise and Peril of Pretomanid-Rifamycin Regimens for Drug-susceptible Tuberculosis
    Velasquez, Gustavo E.
    Nahid, Payam
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207 (07) : 816 - 818
  • [39] Outcomes of Extended Duration Therapy for Drug-Susceptible Cavitary Pulmonary Tuberculosis
    Choi, H.
    Lee, H.
    Sim, Y.
    Shin, T.
    Kim, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [40] First data of a quabodepistat containing novel regimen for drug-susceptible tuberculosis
    Naidoo, Kogieleum
    Perumal, Rubeshan
    LANCET INFECTIOUS DISEASES, 2025, 25 (04) : 366 - 367